<?xml version="1.0" encoding="UTF-8"?>
<p id="p0030">Currently, there is no therapeutic agent or vaccination for the treatment of SARS-CoV-2. In the present scenario, patients are administrated with a combination of drugs such as remdesivir, lopinavir, etc. [
 <xref rid="bib18" ref-type="bibr">18</xref>], hydroxychloroquine, azithromycin, zinc sulfate and corticosteroids. Patients with severe infections are treated by collateral care like ventilation and fluid management. So, discovering a novel therapeutic approach that could help in the control, prevention, and treatment of SARS-CoV-2 infection is an urgent need to save the entire globe from this pandemic situations.
</p>
